Andrx Pharmaceuticals, Inc. v. Friedman

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• finding no antitrust injury based on a generic company’s allegations of illegal collusion because the plaintiff had not yet obtained FDA approval; reasoning that even in absence of the challenged agreement, the plaintiff would not be able to lawfully market its drug

Source: CourtListener parenthetical corpus (CC0).